Anthony Mega

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Andrea B. Apolo, Jeffrey R. Infante, Ani Sarkis Balmanoukian et al. · Journal of Clinical Oncology · 2017 · 580 citations

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 173 citations

Urology, Genitourinary Cancer, Kidney Research +8

PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label single‐arm phase 2 study

Daniel P. Petrylak, Nicholas J. Vogelzang, Kamal Chatta et al. · The Prostate · 2019 · 82 citations

Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol‐dependent manner

Stephen E. Henrich, Kaylin M. McMahon, Michael P. Plebanek et al. · Journal of Extracellular Vesicles · 2020 · 69 citations · Full text

Biological Microenvironments, Pathology, Extracellular Microvesicles +25